Rafferty Asset Management, LLC Amneal Pharmaceuticals, Inc. Transaction History
Rafferty Asset Management, LLC
- $28.9 Billion
- Q3 2024
A detailed history of Rafferty Asset Management, LLC transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 18,844 shares of AMRX stock, worth $158,101. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,844
Previous 17,247
9.26%
Holding current value
$158,101
Previous $109,000
43.12%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding AMRX
# of Institutions
185Shares Held
141MCall Options Held
57KPut Options Held
49K-
Ubs Group Ag21.8MShares$183 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.6MShares$123 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$103 Million2.45% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$94.7 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY10.7MShares$90 Million2.48% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.27B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...